aluates Reports

$ 0.0

Automative

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-19I2859

Global PARP Poly ADP ribose Polymerase Inhibitors Market Insights Forecast to 2028

BUY CHAPTERS

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Insights, Forecast to 2030

Code: QYRE-Auto-19I2859

Report

December 2024

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Pfizer Inc

Astrazeneca plc

GlaxoSmithKline PLC

Clovis Oncology

Everest Pharmaceuticals

PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size

The global PARP (Poly ADP-ribose Polymerase) Inhibitors market is projected to grow from US$ 3917.3 million in 2024 to US$ 21490 million by 2030, at a Compound Annual Growth Rate (CAGR) of 32.8% during the forecast period.

PARP (Poly ADP-ribose Polymerase) Inhibitors Market

PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.

Market Analysis and Insights: Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market

The US & Canada market for PARP (Poly ADP-ribose Polymerase) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for PARP (Poly ADP-ribose Polymerase) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for PARP (Poly ADP-ribose Polymerase) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of PARP (Poly ADP-ribose Polymerase) Inhibitors include AbbVie, Pfizer, AstraZeneca, GlaxoSmithKline, Clovis Oncology and Everest Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

PARP (Poly ADP-ribose Polymerase) Inhibitors is widely used in various fields, such as Ovarian Cancer, Breast Cancer and Other,, etc. Ovarian Cancer provides greatest supports to the PARP (Poly ADP-ribose Polymerase) Inhibitors industry development. In 2023, global % revenue of PARP (Poly ADP-ribose Polymerase) Inhibitors went into Ovarian Cancer filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for PARP (Poly ADP-ribose Polymerase) Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of PARP (Poly ADP-ribose Polymerase) Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for PARP (Poly ADP-ribose Polymerase) Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PARP (Poly ADP-ribose Polymerase) Inhibitors revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for PARP (Poly ADP-ribose Polymerase) Inhibitors revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of PARP (Poly ADP-ribose Polymerase) Inhibitors Market Report

Report Metric	Details
Report Name	PARP (Poly ADP-ribose Polymerase) Inhibitors Market
Accounted market size in 2024	US$ 3917.3 million
Forecasted market size in 2030	US$ 21490 million
CAGR	32.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Olaparib Talazoparib
Segment by Application	Ovarian Cancer Breast Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Pfizer, AstraZeneca, GlaxoSmithKline, Clovis Oncology, Everest Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of PARP (Poly ADP-ribose Polymerase) Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PARP (Poly ADP-ribose Polymerase) Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PARP (Poly ADP-ribose Polymerase) Inhibitors revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is PARP (Poly ADP-ribose Polymerase) Inhibitors Market growing?

Ans: The PARP (Poly ADP-ribose Polymerase) Inhibitors Market witnessing a CAGR of 32.8 during the forecast period 2025-2030.

What is the PARP (Poly ADP-ribose Polymerase) Inhibitors Market size in 2030?

Ans: The PARP (Poly ADP-ribose Polymerase) Inhibitors Market size in 2030 will be US$ 21490 million.

Who are the main players in the PARP (Poly ADP-ribose Polymerase) Inhibitors Market report?

Ans: The main players in the PARP (Poly ADP-ribose Polymerase) Inhibitors Market are AbbVie, Pfizer, AstraZeneca, GlaxoSmithKline, Clovis Oncology, Everest Pharmaceuticals

What are the Application segmentation covered in the PARP (Poly ADP-ribose Polymerase) Inhibitors Market report?

Ans: The Applications covered in the PARP (Poly ADP-ribose Polymerase) Inhibitors Market report are Ovarian Cancer, Breast Cancer, Other

What are the Type segmentation covered in the PARP (Poly ADP-ribose Polymerase) Inhibitors Market report?

Ans: The Types covered in the PARP (Poly ADP-ribose Polymerase) Inhibitors Market report are Olaparib, Talazoparib

Recommended Reports

Cancer Inhibitors

Targeted Therapies

Anticancer Agents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Olaparib

1.2.3 Talazoparib

1.3 Market by Application

1.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Ovarian Cancer

1.3.3 Breast Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2019-2030)

2.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Region

2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Region (2019-2024)

2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2025-2030)

2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Dynamics

2.3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Trends

2.3.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers

2.3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges

2.3.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue PARP (Poly ADP-ribose Polymerase) Inhibitors by Players

3.1.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2019-2024)

3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2019-2024)

3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio

3.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2023

3.5 Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors Head office and Area Served

3.6 Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors, Product and Application

3.7 Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Type

4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2019-2024)

4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2025-2030)

5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application

5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Application (2019-2024)

5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2019-2030)

6.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

6.2.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024)

6.2.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030)

6.2.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

6.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024)

6.3.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030)

6.3.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

6.4 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

6.4.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2019-2024)

6.4.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2019-2030)

7.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

7.2.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024)

7.2.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030)

7.2.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

7.3.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024)

7.3.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030)

7.3.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

7.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

7.4.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2019-2024)

7.4.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2019-2030)

8.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

8.2.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024)

8.2.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030)

8.2.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

8.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

8.3.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024)

8.3.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030)

8.3.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2019-2030)

9.2 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

9.2.1 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024)

9.2.2 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030)

9.2.3 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

9.3 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

9.3.1 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024)

9.3.2 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030)

9.3.3 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

9.4 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region

9.4.1 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2019-2024)

9.4.3 Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

10.2.1 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

10.3.1 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

10.4.1 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

11.1.5 AbbVie Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

11.2.5 Pfizer Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

11.3.5 AstraZeneca Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Developments

11.5 Clovis Oncology

11.5.1 Clovis Oncology Company Details

11.5.2 Clovis Oncology Business Overview

11.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

11.5.5 Clovis Oncology Recent Developments

11.6 Everest Pharmaceuticals

11.6.1 Everest Pharmaceuticals Company Details

11.6.2 Everest Pharmaceuticals Business Overview

11.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

11.6.5 Everest Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AbbVie

Pfizer Inc

Astrazeneca plc

GlaxoSmithKline PLC

Clovis Oncology

Everest Pharmaceuticals

List of Tables

Table 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Olaparib

Table 3. Key Players of Talazoparib

Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2019-2024)

Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2025-2030)

Table 10. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends

Table 11. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers

Table 12. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges

Table 13. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints

Table 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Players (2019-2024)

Table 16. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2023)

Table 17. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors, Headquarters and Area Served

Table 20. Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors, Product and Application

Table 21. Global Key Players of PARP (Poly ADP-ribose Polymerase) Inhibitors, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2019-2024)

Table 25. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2025-2030)

Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application (2019-2024)

Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application (2025-2030)

Table 31. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2025-2030) & (US$ Million)

Table 45. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 46. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 47. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 48. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2025-2030) & (US$ Million)

Table 63. AbbVie Company Details

Table 64. AbbVie Business Overview

Table 65. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 66. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024) & (US$ Million)

Table 67. AbbVie Recent Developments

Table 68. Pfizer Company Details

Table 69. Pfizer Business Overview

Table 70. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 71. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024) & (US$ Million)

Table 72. Pfizer Recent Developments

Table 73. AstraZeneca Company Details

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 76. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024) & (US$ Million)

Table 77. AstraZeneca Recent Developments

Table 78. GlaxoSmithKline Company Details

Table 79. GlaxoSmithKline Business Overview

Table 80. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 81. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024) & (US$ Million)

Table 82. GlaxoSmithKline Recent Developments

Table 83. Clovis Oncology Company Details

Table 84. Clovis Oncology Business Overview

Table 85. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 86. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024) & (US$ Million)

Table 87. Clovis Oncology Recent Developments

Table 88. Everest Pharmaceuticals Company Details

Table 89. Everest Pharmaceuticals Business Overview

Table 90. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 91. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024) & (US$ Million)

Table 92. Everest Pharmaceuticals Recent Developments

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2023 VS 2030

Figure 3. Olaparib Features

Figure 4. Talazoparib Features

Figure 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2023 VS 2030

Figure 7. Ovarian Cancer Case Studies

Figure 8. Breast Cancer Case Studies

Figure 9. Other Case Studies

Figure 10. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered

Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region: 2023 VS 2030

Figure 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2023

Figure 15. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2023

Figure 17. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

Figure 19. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

Figure 20. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2019-2030)

Figure 21. United States PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

Figure 25. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

Figure 26. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2019-2030)

Figure 27. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

Figure 35. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

Figure 36. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

Figure 38. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

Figure 39. Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2019-2030)

Figure 40. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2019-2030)

Figure 50. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

Figure 57. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

Figure 58. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

Figure 59. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

Figure 60. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

Figure 61. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global PARP Poly ADP Ribose Polymerase Inhibitor Market Research Report 2025

PARP Inhibitors for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Drug based on PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enzyme Poly ADP Ribose Polymerase PARP Inhibitor Market Insights Forecast to 2030

Global PARP Inhibitors for Breast Cancer Market Research Report 2024

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Insights Forecast to 2030

DNA Repair PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Niraparib API Market Research Report 2024

Global Olaparib API Market Research Report 2024

Global Niraparib Preparations Market Research Report 2024

Global PARP Inhibitor Biomarkers Service Market Research Report 2024

Global PARP Inhibitor Biomarkers Testing Product Market Research Report 2024

Global PARP1 Antibody Market Research Report 2024

Targeting DNA Repair Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

DNA Repair Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Platinum based Anticancer APIs Market Research Report 2024

Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PORCN Inhibitor Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions